Through an amicus brief submitted to the U.S. Ninth Circuit Court of Appeals, End of Life Washington (EOLWA), declared its support for the application of federal Right to Try laws so that terminally ill Washingtonians can access psilocybin therapy as a palliative care option. The amicus brief is presented as part of a lawsuit filed by Seattle-based Advanced Integrative Medical Science Institute against the federal Drug Enforcement Administration.
The lawsuit seeks to demonstrate that the DEA’s views act as a barrier to the federal Right To Try laws, and in turn, blocks a promising treatment for terminally ill patients, deterring physicians from using psilocybin for fear of legal prosecution, and suggesting that psilocybin could be administered by physicians but only in a research capacity.
“Dying Washingtonians deserve the full range of treatments for their emotional and physical care, and cannot afford to wait months or years for a completed research project,” said Judy Kinney, EOLWA Executive Director, said in a statement.
Psilocybin is one of the chemical compounds found in what’s known as hallucinogenic or “magic” mushrooms. Numerous peer-reviewed, clinical studies have demonstrated that psilocybin, if taken under controlled conditions, produces significant and enduring positive effects, such as reducing depression, improving death acceptance, and improving levels of optimism.